Replies to post #104 on CorMedix Inc (CRMD)

[xrymd]

A very educated guess is a partner for the phase 3 trial. The word is likely out for the chosen few

[celtic]

For starters
http://finance.yahoo.com/news/fda-grants-qidp-designation-neutrolin-140000338.html

Takeover should be a minimum of $6 imo...If multiple offers $9/$10...might be better now to stay independent but imo Elliot & Mgt will take a good offer...either way stock ridiculously undervalued...


Ridiculous - the post marketing followup in EU and other trials make the Ph 3 a quick slam dunk...expect companies who Pfaffle has talked to about running the Ph 3 to suddenly want to take this company over - an unencumbered anti-microbial with no US competition until 2030+ and huge upside in Europe on legal settlement . Insanely low market cap here in the 2's.